- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Treatment of Relapsed Acute Lymphocytic Leukemia in Adult Patients ; volume:25 ; number:8 ; day:25 ; month:6 ; year:2024 ; pages:993-1010 ; date:8.2024
Current treatment options in oncology ; 25, Heft 8 (25.6.2024), 993-1010, 8.2024
- Creator
-
Molina, John C.
Carraway, Hetty E.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s11864-024-01213-4
- URN
-
urn:nbn:de:101:1-2411032113494.160588394913
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Molina, John C.
- Carraway, Hetty E.
- SpringerLink (Online service)
Other Objects (12)
Relapsed Acute Lymphoblastic Leukemia
Advances in the treatment of relapsed/refractory chronic lymphocytic leukemia
Update on the management of relapsed/refractory chronic lymphocytic leukemia
Treatment of Relapsed Acute Myeloid Leukemia
Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemia
FLT3 mutations in canine acute lymphocytic leukemia
Treatment of Adult Patients with Relapsed/Refractory B-Cell Philadelphia-Negative Acute Lymphoblastic Leukemia
Chronic lymphocytic leukemia
Chronic lymphocytic leukemia
Chronic lymphocytic leukemia
Serum peptidome based biomarkers searching for monitoring minimal residual disease in adult acute lymphocytic leukemia
Next-Generation Sequencing—Optimal Sequencing of Therapies in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
Relapsed Acute Lymphoblastic Leukemia
Advances in the treatment of relapsed/refractory chronic lymphocytic leukemia
Update on the management of relapsed/refractory chronic lymphocytic leukemia
Treatment of Relapsed Acute Myeloid Leukemia
Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemia
FLT3 mutations in canine acute lymphocytic leukemia
Treatment of Adult Patients with Relapsed/Refractory B-Cell Philadelphia-Negative Acute Lymphoblastic Leukemia
Chronic lymphocytic leukemia
Chronic lymphocytic leukemia
Chronic lymphocytic leukemia
Serum peptidome based biomarkers searching for monitoring minimal residual disease in adult acute lymphocytic leukemia
Next-Generation Sequencing—Optimal Sequencing of Therapies in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
Relapsed Acute Lymphoblastic Leukemia
Advances in the treatment of relapsed/refractory chronic lymphocytic leukemia
Update on the management of relapsed/refractory chronic lymphocytic leukemia
Treatment of Relapsed Acute Myeloid Leukemia
Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemia
FLT3 mutations in canine acute lymphocytic leukemia
Treatment of Adult Patients with Relapsed/Refractory B-Cell Philadelphia-Negative Acute Lymphoblastic Leukemia
Chronic lymphocytic leukemia
Chronic lymphocytic leukemia
Chronic lymphocytic leukemia
Serum peptidome based biomarkers searching for monitoring minimal residual disease in adult acute lymphocytic leukemia